The emerging issue of cardiovascular involvement in familial mediterranean fever

Archives of Medical Science

Volumn 4, Issue 4, 2008, Pages 465-467

  Gasparyan, Armen Yuri ^a   Ugurlucan, Murat ^b  

^a DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG EFFICACY; EDITORIAL; FAMILIAL MEDITERRANEAN FEVER; HEART AMYLOIDOSIS; HEART FUNCTION TEST; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; PATHOPHYSIOLOGY; PATIENT MONITORING; PROGNOSIS; RAYNAUD PHENOMENON; RISK REDUCTION; VASCULITIS;

EID: 60249086027     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (12)

1. Gasparyan AY, Petrosyan AH. Cardiovascular involvement in familial Mediterranean fever. Cardiovasc Ther Prev 2007; 6: 117-24.
2. Nazaretyan EY, Gasparyan AY. Contemporary issues of periodic disease. Med Sci Arm 2000; 40: 35-41.
3. Ben-Chetrit E, Levy M. Familial Mediterranean Fever. Lancet 1998; 351: 659-64.
4. Gasparyan AY, Nazaretyan EY, Narimanyan MZ. Predominant cardiac lesion in periodic disease (familial Mediterranean fever). Russ Fam Phys 2001; 5: 50-3.
5. Akdogan A, Calguneri M, Yavuz B, et al. Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 2006; 48: 2351-3.
6. Korkmaz C, Ozdogan H, Kasapçopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 2002; 61: 79-81.
7. Korkmaz C, Zubaroglu I, Kaya T, Akçar N, Gürbüz E, Ozen S. A case of familial Mediterranean fever, Behçet's disease and polyarteritis nodosa complicated by perirenal haematoma. Clin Exp Rheumatol 2001; 19 (5 Suppl 24): S78-9.
8. Hatemi G, Masatlioglu S, Gogus F, Ozdogan H. Necrotizing vasculitis associated with familial Mediterranean fever. Am J Med 2004; 117: 516-9.
9. Langevitz P, Livneh A, Neumann L, et al. Prevalence of ischemic heart disease in patients with familial Mediterranean fever. Isr Med Assoc J 2001; 3: 9-12.
10. Sari I, Karaoglu O, Can G, et al. Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 2007; 26: 1467-73.
11. Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med 1972; 287: 1302.
12. Cocco G. Vasculitis, left bundle branch block and Raynaud's phenomenon as a manifestation of familial Mediterranean fever. Arch Med Sci 2008; 4: 460-4.